High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Drug treatment for spinal muscular atrophy types II and IIITreatment for cramps in amyotrophic lateral sclerosis/motor neuron diseaseRiluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)Drug treatment for spinal muscular atrophy types II and IIITreatment for familial amyotrophic lateral sclerosis/motor neuron diseaseDrug treatment for spinal muscular atrophy types II and IIIAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesRiluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron DegenerationA comprehensive review of amyotrophic lateral sclerosisComplementary and Alternative Therapies in Amyotrophic Lateral SclerosisOxidative Stress in Neurodegenerative DiseasesRisk factors for amyotrophic lateral sclerosisClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisPhase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALSAn in vitro screening cascade to identify neuroprotective antioxidants in ALSVitamin E and all-cause mortality: a meta-analysis.The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compressionNew Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injury.Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.Unleashing the untold and misunderstood observations on vitamin E.Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the AmMultidisciplinary Interventions in Motor Neuron Disease.Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review.Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials.Plasma and tissue concentrations of α-tocopherol and δ-tocopherol following high dose dietary supplementation in mice.Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease.Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising future.Clinical trials in ALS: what did we learn from recent trials in humans?Preclinical trials--an update on translational research in ALS.Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis.Nutrition and dietary supplements in motor neuron disease.
P2860
Q21090716-6CBE86BA-EBFF-4029-9B2A-2998BB21CF06Q24200270-358C9ADB-1054-4AF5-A0EC-7FF5FA37C500Q24200285-AF300641-4BEB-4436-98F5-ECF964D92E95Q24201081-E3F2C0C5-E0E0-4D1D-AA66-A2418963695EQ24234414-766EBFA2-EAE8-4ACB-AE10-134A27754633Q24241570-95CDDD40-F314-43E3-829D-A4505B213EECQ24241759-0837C40A-BACF-4101-AA59-E8D12C4638ECQ24242944-8CC9FE37-AEB9-431C-9D33-6FD8A4E80312Q24246517-7D6C2F25-2403-43AD-9D1B-6FA93E903003Q26766040-ABEAEF98-D225-4572-95E5-584C49752074Q26775401-FA436D52-08D1-4726-B4DF-584D9A398C5AQ26777929-9E3419EE-698A-4AE2-8E3D-60D3041A9556Q26801239-6F0635EC-472E-4A35-84A5-24522979B9B2Q26827642-90328469-89CC-48F0-BFAE-FFF4BA6E8844Q28392768-4C9FB02C-1AC1-466A-9F8C-68FFA2C014F8Q30494108-2985BD11-3E07-414E-BCFE-E591FDB7A8DBQ33358054-489FE82C-62B2-4E91-A6BC-B86B168680B9Q33445432-9D4DCB69-6329-4EC0-9959-9DA73440840AQ33649141-E0DCEEBE-DB24-4BB0-B24F-15D19B41884CQ33747031-CDA839BD-B8D6-439C-B06D-D6ECB9E53FE9Q33783000-56489F14-DE30-4D3B-9138-286E022CBE3EQ33824784-5E1731D6-E763-4DF9-8BFB-83E7261754C5Q34104378-7B7DFF1D-0385-4360-8026-AF59CC7F8B76Q34110860-111E5E23-B605-416D-9B58-169FC78EBB35Q34222849-7343F601-213E-4127-A1A9-46499588178AQ34401653-DE5A54E8-FF51-4E3A-90D4-C4BFAE4E48AEQ34571459-47929464-AD71-4675-9E1D-D90759E757E4Q34581614-17444813-3838-41F9-9B69-2CD3229D76AEQ35007618-97A33D31-7468-4C42-B3C6-9D80EBA2F0AFQ35623262-B9C1115E-C584-4588-A3C1-0779726AFDABQ35630224-42953F76-92A3-49B5-A477-01D83FF4C604Q35671076-453E6347-C98E-4D46-873B-1E8E0ECF4CA1Q36096378-1FD7EC59-E222-4283-9197-11FD16107F38Q36265215-F158FEE6-67F6-4166-82C8-DFD7EB7802CDQ36314443-47F08B2A-EB95-44A1-B727-156616EF2E3FQ36565680-6E056805-34D9-47D3-A352-CEA0D03F51F4Q36565682-79835F1D-49E6-433D-8B79-AE9174D9DE4CQ36904550-8FA02A79-7C2D-464D-B88E-93E3F8B0C1CFQ37008837-CD8754A4-4213-4E60-B587-6C76C8023444Q37073851-363FB34E-0321-4DAA-B212-BA27B6F10B4F
P2860
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
High dose vitamin E therapy in ...... controlled double-blind study.
@ast
High dose vitamin E therapy in ...... controlled double-blind study.
@en
High dose vitamin E therapy in ...... controlled double-blind study.
@nl
type
label
High dose vitamin E therapy in ...... controlled double-blind study.
@ast
High dose vitamin E therapy in ...... controlled double-blind study.
@en
High dose vitamin E therapy in ...... controlled double-blind study.
@nl
prefLabel
High dose vitamin E therapy in ...... controlled double-blind study.
@ast
High dose vitamin E therapy in ...... controlled double-blind study.
@en
High dose vitamin E therapy in ...... controlled double-blind study.
@nl
P2093
P921
P1476
High dose vitamin E therapy in ...... controlled double-blind study.
@en
P2093
A C Ludolph
B Neundörfer
P2888
P304
P356
10.1007/S00702-004-0220-1
P577
2004-10-27T00:00:00Z